WA
AVNS

Winfield Associates’s Avanos Medical AVNS Stock Holding History

Winfield Associates’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-37
Closed -$1K – 727
2016
Q3 		$1K Hold
37
– – ﹤0.01% 586
2016
Q2 		$1K Hold
37
– – ﹤0.01% 583
2016
Q1 		$1K Hold
37
– – ﹤0.01% 555
2015
Q4 		$1K Buy
+37
New +$1.15K ﹤0.01% 296
2015
Q3 		– Sell
-2,700
Closed -$109K – 302
2015
Q2 		$109K Hold
2,700
– – 0.07% 131
2015
Q1 		$133K Buy
+2,700
New +$125K 0.09% 127

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Winfield Associates's AVNS Position: Q4 2016 in Review

Winfield Associates sold out of Avanos Medical (AVNS) in Q4 2016, closing a stake of 37 shares — an estimated $1K sold.

Winfield Associates first reported a position in AVNS in Q1 2015 and held it in 6 quarters. The position peaked at $133K in Q1 2015. 360 funds tracked by Wall St. Rank hold AVNS as of Q4 2016.

  • Winfield Associates reported no remaining Avanos Medical position as of Q4 2016 after selling out during the quarter.
  • Winfield Associates sold 37 Avanos Medical shares in Q4 2016, an estimated $1K.
  • Winfield Associates first reported a position in Avanos Medical in Q1 2015 and held it in 6 quarters.
  • Winfield Associates's Avanos Medical position peaked at $133K in Q1 2015.
  • 360 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2016.

Based on Winfield Associates's 13F filing for Q4 2016, filed 20 Jan 2017.